Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

TetraLogic Pharmaceuticals Corporation (TLOG) growth grade and underlying metrics. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two ...

At close: 28 November at 4:00:00 pm GMT-5 ...

TetraLogic Pharmaceuticals Corp. Annual cash flow by MarketWatch. View TLOG net cash flow, operating cash flow, operating expenses and cash dividends.

As of December 1 at 4:00:00 PM EST. Market Open. Get top stock picks Research reports are not currently available for TLOG.